Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of Business (Details Narrative)

v3.21.1
Organization and Description of Business (Details Narrative) - $ / shares
Apr. 16, 2021
Apr. 16, 2021
Mar. 23, 2020
Membership Interest Purchase Agreement [Member]      
Ownership pecentage     100.00%
Subsequent Event [Member] | Merger Agreement [Member]      
Option to purchase shares of common stock 4,188,315    
MyMD Pharmaceuticals (Florida), Inc [Member] | Subsequent Event [Member]      
Common stock par value $ 0.001 $ 0.001  
Exchange ratio price per shares $ 0.7718 $ 0.7718  
Reverse stock split   1-for-2 reverse stock split  
Warrants to purchase 986,486 986,486  
Option to purchase shares of common stock   4,188,315  
Ownership pecentage 22.95% 22.95%  
MyMD Pharmaceuticals (Florida), Inc [Member] | Subsequent Event [Member] | Merger Agreement [Member]      
Ownership pecentage 77.05% 77.05%